CY1117243T1 - Στερεοεκλεκτικη μεθοδος και κρυσταλλικες μορφες μιας καμπτοθεκινης - Google Patents
Στερεοεκλεκτικη μεθοδος και κρυσταλλικες μορφες μιας καμπτοθεκινηςInfo
- Publication number
- CY1117243T1 CY1117243T1 CY20121101034T CY121101034T CY1117243T1 CY 1117243 T1 CY1117243 T1 CY 1117243T1 CY 20121101034 T CY20121101034 T CY 20121101034T CY 121101034 T CY121101034 T CY 121101034T CY 1117243 T1 CY1117243 T1 CY 1117243T1
- Authority
- CY
- Cyprus
- Prior art keywords
- stereoelective
- cambodothein
- crystal forms
- gimatecan
- butyloxyiminomethyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- UIVFUQKYVFCEKJ-OPTOVBNMSA-N gimatecan Chemical compound C1=CC=C2C(\C=N\OC(C)(C)C)=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UIVFUQKYVFCEKJ-OPTOVBNMSA-N 0.000 abstract 2
- 229950009073 gimatecan Drugs 0.000 abstract 2
- 230000000707 stereoselective effect Effects 0.000 abstract 2
- 229940127093 camptothecin Drugs 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000004062 sedimentation Methods 0.000 abstract 1
- 239000011877 solvent mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04030246 | 2004-12-21 | ||
| EP05849781A EP1828196B1 (en) | 2004-12-21 | 2005-12-16 | Stereoselective process and crystalline forms of a camptothecin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117243T1 true CY1117243T1 (el) | 2017-04-05 |
Family
ID=34927884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121101034T CY1117243T1 (el) | 2004-12-21 | 2012-10-30 | Στερεοεκλεκτικη μεθοδος και κρυσταλλικες μορφες μιας καμπτοθεκινης |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US7799921B2 (enExample) |
| EP (1) | EP1828196B1 (enExample) |
| JP (2) | JP5491699B2 (enExample) |
| KR (1) | KR101355121B1 (enExample) |
| CN (1) | CN101084221B (enExample) |
| AU (1) | AU2005318227B2 (enExample) |
| BR (1) | BRPI0515832A (enExample) |
| CA (1) | CA2590756C (enExample) |
| CY (1) | CY1117243T1 (enExample) |
| DK (1) | DK1828196T3 (enExample) |
| ES (1) | ES2395930T3 (enExample) |
| HR (1) | HRP20120926T1 (enExample) |
| ME (1) | ME01495B (enExample) |
| PL (1) | PL1828196T3 (enExample) |
| PT (1) | PT1828196E (enExample) |
| RS (1) | RS52585B (enExample) |
| SI (1) | SI1828196T1 (enExample) |
| WO (1) | WO2006067092A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1828196B1 (en) * | 2004-12-21 | 2012-10-17 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Stereoselective process and crystalline forms of a camptothecin |
| ITRM20050418A1 (it) * | 2005-08-04 | 2007-02-05 | Sigma Tau Ind Farmaceuti | Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina. |
| FR2938534B1 (fr) | 2008-11-14 | 2012-10-26 | Sanofi Aventis | Procede de preparation de l'hemifumarate d'eplivanserine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03271278A (ja) * | 1990-03-16 | 1991-12-03 | Nissan Chem Ind Ltd | ２―アニリノピリミジン誘導体および農園芸用殺菌剤 |
| JP3046401B2 (ja) * | 1991-06-18 | 2000-05-29 | イハラケミカル工業株式会社 | ６−〔１−（ｎ−アルコキシイミノ）エチル〕サリチル酸誘導体及びその製造法 |
| IL106786A (en) * | 1992-09-10 | 1997-02-18 | Basf Ag | Substituted pyridine derivatives and fungicidal compositions containing them |
| EP1044977B1 (en) * | 1999-03-09 | 2002-05-02 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Camptothecin derivatives having antitumor activity |
| AU2003215594A1 (en) * | 2002-03-01 | 2003-09-16 | Pharmacia Italia S.P.A. | Crystalline polymorphic form of irinotecan hydrochloride |
| EP1828196B1 (en) * | 2004-12-21 | 2012-10-17 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Stereoselective process and crystalline forms of a camptothecin |
-
2005
- 2005-12-16 EP EP05849781A patent/EP1828196B1/en not_active Expired - Lifetime
- 2005-12-16 HR HRP20120926TT patent/HRP20120926T1/hr unknown
- 2005-12-16 ME MEP-2012-128A patent/ME01495B/me unknown
- 2005-12-16 PT PT05849781T patent/PT1828196E/pt unknown
- 2005-12-16 DK DK05849781.9T patent/DK1828196T3/da active
- 2005-12-16 CA CA2590756A patent/CA2590756C/en not_active Expired - Fee Related
- 2005-12-16 ES ES05849781T patent/ES2395930T3/es not_active Expired - Lifetime
- 2005-12-16 KR KR1020077016814A patent/KR101355121B1/ko not_active Expired - Fee Related
- 2005-12-16 PL PL05849781T patent/PL1828196T3/pl unknown
- 2005-12-16 SI SI200531610T patent/SI1828196T1/sl unknown
- 2005-12-16 AU AU2005318227A patent/AU2005318227B2/en not_active Ceased
- 2005-12-16 CN CN2005800440829A patent/CN101084221B/zh not_active Expired - Lifetime
- 2005-12-16 WO PCT/EP2005/056849 patent/WO2006067092A2/en not_active Ceased
- 2005-12-16 RS RS20120505A patent/RS52585B/sr unknown
- 2005-12-16 US US11/721,282 patent/US7799921B2/en not_active Expired - Fee Related
- 2005-12-16 JP JP2007547467A patent/JP5491699B2/ja not_active Expired - Fee Related
- 2005-12-16 BR BRPI0515832-0A patent/BRPI0515832A/pt not_active Application Discontinuation
-
2010
- 2010-08-17 US US12/857,743 patent/US8124769B2/en not_active Expired - Fee Related
- 2010-08-17 US US12/857,776 patent/US8101758B2/en not_active Expired - Fee Related
-
2012
- 2012-10-30 CY CY20121101034T patent/CY1117243T1/el unknown
- 2012-11-09 JP JP2012247587A patent/JP5982261B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20100311783A1 (en) | 2010-12-09 |
| HK1113487A1 (en) | 2008-10-03 |
| WO2006067092A3 (en) | 2006-11-02 |
| EP1828196A2 (en) | 2007-09-05 |
| RS52585B (sr) | 2013-04-30 |
| US7799921B2 (en) | 2010-09-21 |
| CN101084221B (zh) | 2011-05-11 |
| PL1828196T3 (pl) | 2013-02-28 |
| AU2005318227A1 (en) | 2006-06-29 |
| EP1828196B1 (en) | 2012-10-17 |
| ES2395930T3 (es) | 2013-02-18 |
| KR101355121B1 (ko) | 2014-01-24 |
| JP5982261B2 (ja) | 2016-08-31 |
| CN101084221A (zh) | 2007-12-05 |
| US8124769B2 (en) | 2012-02-28 |
| PT1828196E (pt) | 2012-11-19 |
| KR20070097535A (ko) | 2007-10-04 |
| US20090239893A1 (en) | 2009-09-24 |
| JP2013067629A (ja) | 2013-04-18 |
| ME01495B (me) | 2014-04-20 |
| DK1828196T3 (da) | 2012-11-26 |
| BRPI0515832A (pt) | 2008-08-05 |
| CA2590756C (en) | 2014-09-02 |
| US20100311784A1 (en) | 2010-12-09 |
| JP5491699B2 (ja) | 2014-05-14 |
| JP2008524306A (ja) | 2008-07-10 |
| CA2590756A1 (en) | 2006-06-29 |
| WO2006067092A2 (en) | 2006-06-29 |
| HRP20120926T1 (hr) | 2012-12-31 |
| SI1828196T1 (sl) | 2012-12-31 |
| AU2005318227B2 (en) | 2011-08-18 |
| US8101758B2 (en) | 2012-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106726T1 (el) | Υποκατεστημενα βενζοπυρανια ως επιλεκτικοι συναγωνιστες οιστρογονικου υποδοχεα β | |
| BR0008222A (pt) | Produção de derivados de isoflavona | |
| BRPI0212341B8 (pt) | compostos intermediários de inibidores de protease de hiv e processo para preparação dos mesmos | |
| CY1109891T1 (el) | Παραγωγα ν-(αρυλαλκυλ)-1η-πυρρολοπυριδιν-2-καρβοξαμιδιων, η παρασκευη τους και η εφαρμογη τους σε θεραπειες | |
| BR0316056A (pt) | Processo para a preparação de compostos de pirrolotriazina úteis como inibidores de cinase | |
| DK2089371T3 (da) | Fremstillingsmåde til fremstilling af hexahydrofuro[2,3-b]furan-3-OL | |
| DK1580216T3 (da) | Derivater med høj molekylvægt af camptotheciner | |
| CY1112533T1 (el) | Μεθοδοι και ενωσεις για την παρασκευη αναλογων cc-1065 | |
| CY1117243T1 (el) | Στερεοεκλεκτικη μεθοδος και κρυσταλλικες μορφες μιας καμπτοθεκινης | |
| DK1651644T3 (da) | Substituerede derivater af thiazol-benzoisothiazoldioxid, fremgangsmåde deraf og deres anvendelse | |
| CY1113368T1 (el) | Αλας π-τολουολο σουλφονικου οξεος της 5-αμινο-3-(2'-ο-ακετυλ-3'-δεοξυ-βητα-d-ριβοφουρανοζυλ)-3η-θειαζολο[4,5-d]πυριμιδινο-2-ονης και μεθοδοι παρασκευης | |
| CY1115148T1 (el) | Ανθελονοσιακα δισπειρο 1,2,4-τριοξολανια | |
| BR0305256A (pt) | Ativadores de catalizador de polimerização, método de preparação e seu uso em processo de polimerização | |
| CY1112038T1 (el) | Αναστολεις της κινασης τυροσινης | |
| DK1756049T3 (da) | Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater | |
| CY1108244T1 (el) | Παρασκευη μορφης ι καβεργολινης και επιδιαλυτωμενου συμπλοκου αυτης | |
| BR0311282A (pt) | Moduladores sulfona de receptor-x do fìgado | |
| DK1838683T3 (da) | Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater | |
| BRPI0511956A (pt) | processo para a preparação dos compostos, e, intermediários de sìntese | |
| EA200501829A1 (ru) | Способ получения непептидных замещённых спиробензоазепиновых производных | |
| DE602005016282D1 (de) | Verfahren zur herstellung von camptothecin-derivaten | |
| EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| HRP20050039B1 (hr) | Kristalne forme olanzapina i postupci njihove priprave | |
| DK1883640T3 (da) | Fremgangsmåde til fremstilling af chlorider af phthalocyaninderivater der omfatter mindst en kvaternær ammoniumgruppe | |
| DK2004670T3 (da) | Fremgangsmåde til fremstilling af lysobactin-derivater |